fig2
![Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardium](https://image.oaes.cc/86f2c794-f7a4-470b-a892-451b19dcdbe8/vp8095.fig.2.jpg)
Figure 2. Canagliflozin and sitagliptin therapy demonstrate comparable improvements in coronary perfusion to chronically ischemic myocardium. Perfusion expressed as mL/min/g as measured by microsphere analysis shown at rest and during pacing to